Literature DB >> 1370168

Expression of variable exon A-, B-, and C-specific CD45 determinants on peripheral and thymic T cell populations.

K S Hathcock1, G Laszlo, H B Dickler, S O Sharrow, P Johnson, I S Trowbridge, R J Hodes.   

Abstract

A mAb (I/24) has been generated that is specific for a determinant on mouse CD45 molecules. Reactivity of this mAb with a panel of CD45 transfected cell lines demonstrated that the determinant recognized is dependent upon expression of one or more CD45 variable exons and that exon C is sufficient for its expression. The exon C-specific epitope detected by I/24 is expressed at high density on essentially all B lymphocytes and at an intermediate density on the vast majority of CD8+ splenic T cells. Two distinct subpopulations of CD4+ splenic T cells were detected, a minor subpopulation that expresses this exon determinant at high density and a major subpopulation that expresses it at a much lower density. This first identification of a CD45RC-specific reagent allowed a comparison of the expression of exon A-, exon B-, and exon C-specific determinants on peripheral and thymic lymphoid populations. When splenic lymphocytes were analyzed for expression of CD45RA (reactive with mAb 14.8), CD45RB (reactive with mAb 23G2 or mAb 16.A), and CD45RC (reactive with mAb I/24) determinants, it was found that each of these CD45 determinants had a distinct pattern of expression on CD4+ and CD8+ T cells and B cells. CD45RB and RC epitopes were also detected at high density on a small proportion (0.7 to 4.1%) of thymocytes. Both CD45RB and RC epitopes were found predominantly on CD4-CD8- and CD4-CD8+ thymocytes but were also found on small numbers of CD4+CD8+ and CD4+CD8- cells. The population of thymocytes that expressed CD45RB and CD45RC determinants displayed a novel TCR CD3 phenotype characterized by a level of expression that was intermediate between that seen in the larger CD3 bright and CD3 dull populations of thymocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370168

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  CD45 expression by murine B cells and T cells: alteration of CD45 isoforms in subpopulations of activated B cells.

Authors:  K S Hathcock; H Hirano; R J Hodes
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

2.  Engagement of the external domains of CD45 tyrosine phosphatase can regulate the differentiation of immature CD4+CD8+ thymocytes into mature T cells.

Authors:  P Benveniste; Y Takahama; D L Wiest; T Nakayama; S O Sharrow; A Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

3.  Antibody-mediated targeting of CD45 isoforms: a novel immunotherapeutic strategy.

Authors:  G P Basadonna; L Auersvald; C Q Khuong; X X Zheng; N Kashio; D Zekzer; M Minozzo; H Qian; L Visser; A Diepstra; A I Lazarovits; S Poppema; T B Strom; D M Rothstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

4.  9-O-Acetylation of sialomucins: a novel marker of murine CD4 T cells that is regulated during maturation and activation.

Authors:  M Krishna; A Varki
Journal:  J Exp Med       Date:  1997-06-02       Impact factor: 14.307

5.  N- and O-glycans modulate galectin-1 binding, CD45 signaling, and T cell death.

Authors:  Lesley A Earl; Shuguang Bi; Linda G Baum
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

6.  Subpopulations of guinea-pig T lymphocytes defined by isoforms of the leucocyte common antigen.

Authors:  I J Hart; H Schäfer; R J Scheper; G T Stevenson
Journal:  Immunology       Date:  1992-11       Impact factor: 7.397

7.  Specific CD45 isoforms differentially regulate T cell receptor signaling.

Authors:  D Chui; C J Ong; P Johnson; H S Teh; J D Marth
Journal:  EMBO J       Date:  1994-02-15       Impact factor: 11.598

8.  The extracellular domain of CD45 controls association with the CD4-T cell receptor complex and the response to antigen-specific stimulation.

Authors:  D Leitenberg; T J Novak; D Farber; B R Smith; K Bottomly
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

9.  CD45RA and CD45RBhigh expression induced by thymic selection events.

Authors:  V A Wallace; W P Fung-Leung; E Timms; D Gray; K Kishihara; D Y Loh; J Penninger; T W Mak
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.